Navigation Links
Mail-Order Drugs: Deal or No Deal?

Buyers beware. Businesses that encourage employees to order prescription drugs through the mail may not be reaping the financial rewards they think they are//.

In recent years, mail-order pharmacies, owned by pharmacy-benefit managers (PBMs), have become popular among cost-conscious companies offering prescription benefits to their employees. Their belief – supported by a 2005 Federal Trade Commission (FTC) report – is that, overall, drugs purchased by mail cost a lot less than those bought from retail pharmacies.

Not so, according to a new study from the Creighton University School of Pharmacy and Health Professions in Omaha, which disputes the FTC report findings. The study appears in the January issue of Drug Benefit Trends.

“We found that brand-name drugs were slightly less expensive when purchased by mail, but generic drugs were more expensive by mail. When we combine the prices for brand-name and generic prescriptions, any differences virtually disappear,’ said Robert I. Garis, M.B.A., Ph.D., associate professor at the Creighton University School of Pharmacy and Health Professions.

Both the FTC report and the Creighton study were based on 2002 drug prices. Creighton researchers looked at pricing data for the top 50 brand-name and top 50 generic drugs by prescription volume.

The FTC based its report on aggregated price, and the Creighton study priced common drugs according to the terms stated by the FTC. While the use of 2002 data was necessary to compare the Creighton results fairly to the FTC analysis, Garis said the same pricing pattern continues today.

Given a continued increase in generic-drug use by both mail and retail pharmacies and the practice of high markups on generics by PBM-owned mail outlets, he added, retail pharmacies ultimately may offer the better value. He noted that recent reports show generic drugs account for more than 55 percent of all prescriptions dispensed throu gh both mail and retail channels.

“Employers need to ask PBMs more questions about their markups on generics, just as they would when purchasing ink, paper or other supplies,” Garis said. “The truth is that PBMs are racking up record profits through an increased use of generic drugs and an increased use of PBM-owned, mail-order facilities.”

Source-NewswiseBR>SRM
'"/>




Related medicine news :

1. Osteoporosis Drugs: right time to take-off
2. Yoga Can Keep Youths Away From Drugs: Ravi Shankar
3. Antiretroviral Drugs: A Shot in the Arm to Fight Malaria?
4. Addicts in India Taking to Pharmaceutical Drugs: UNAIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... ... Social media marketing is transitioning from a singular person activity to a ... into this insight and more in its latest episode of its Brains Over Brawn ... with social media strategist and partner of the digital firm Med|Ed Digital Jessica Columbo. ...
(Date:2/22/2017)... ... 22, 2017 , ... In a recent article ... context (age, illness and life choices) should be dissociated from medical errors and ... In addition, all too often, studies regarding health system performance in other countries, ...
(Date:2/21/2017)... ... 22, 2017 , ... Author Michèle Wolff has a passion for using ... to know all about it for optimal health. Wanting to share her knowledge to ... Digestive and Wellness Solutions ” (published by Balboa Press AU). , This book ...
(Date:2/21/2017)... ... ... Doctors on Liens has announced the addition of Mendonca Spine Care Center ... network of doctors in Central and Northern California. Dr. Mendonca specializes in personal injury ... pain, neck pain, hip and knee pain, and headaches. Specializing in non-surgical, spinal ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care models requires collaboration across ... data across industry solutions, Fogo Data Centers announces the launch of the Fogo Partner ... community is one in which all systems work well, work together, and work together ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)...  Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical ... the field of urology, today announced the expansion of ... managers from 35 currently, a 20% increase in the ... expansion is being driven by the increasing growth of ... increasing acceptance of Natesto,s unique product profile and clinical ...
(Date:2/22/2017)... February 22, 2017 NetworkNewsWire Editorial Coverage: The ... states in the U.S. have now legalized marijuana for medicinal or ... Canada , Jamaica , ... Portugal , Uruguay and ... decriminalize cannabis in the last two years. As a result, the ...
(Date:2/22/2017)... , Feb. 22, 2017 Kineta, Inc., ... of novel immune modulating therapies, today announced that ... nicotinic acetylcholine receptor (nAChR), demonstrates robust chronic pain ... models. The study also establishes the a9a10 nAChR ... of chronic pain. The findings were reported online ...
Breaking Medicine Technology: